ASCO 2022 Conference Coverage


 

ASCO 2022 Impact of BMI on Treatment and Outcomes in Patients With HR+ EBC Receiving ET +/- Palbociclib in the PALLAS Trial

297 views
June 10, 2022
Comments 0
Login to view comments. Click here to Login